References
- Artursson, P., & Karlsson, J. (1991). Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochemical and Biophysical Research Communications, 175, 880–885., [PUBMED], [INFOTRIEVE], [CSA]
- Cooney, G. F., Jeevanandam, V., Choudhury, S., Feutren, G., Mueller, E. A., & Eisen, H. J. (1998). Comparative bioavailability of Neoral and Sandimmune in cardiac transplant recipients over 1 year. Transplantation, 30, 1892–1894., [CROSSREF]
- Eccleston, G. M. (1992). Microemulsions In: S. Swarbrick & J. C. Boylan (Eds.), Encyclopedia of Pharmaceutical Technology(pp. 375–421). New York: Marcel Dekker.
- Fan, L. L., O'Keefe, D. D.Jr., & Powell, W. J.Jr. (1984). Effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia. Acta Pharmaceutica Sinica, 19, 801–807., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Gao, Z. G., Choi, H. G., Shin, H. J., Park, K. M., Lim, S. J., Hwang, K. J., & Kim, C. K. (1998). Physicochemical characterization and evaluation of a microemulsion system for oral delivery of cyclosporin A. International Journal of Pharmaceutics, 161, 75–86., [CROSSREF]
- Itoh, K., Tozuka, Y., Oguchi, T., & Yamamoto, K. (2002). Improvement of physicochemical properties of N-4472 part I formulation design by using self-microemulsifying system. International Journal of Pharmaceutics, 238, 153–160., [PUBMED], [INFOTRIEVE], [CSA]
- Khoo, S. M., Humberstone, A. J., Porter, C. J. H., Edwards, G. A., & Charman, W. N. (1998). Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. International Journal of Pharmaceutics, 167, 155–164., [CROSSREF]
- Kim, H. J., Yoon, K. A., Hahn, M., Park, E. S., & Chi, S. C. (2000). Preparation and in vitro evaluation of self-microemulsifying drug delivery systems containing idebenone. Drug Development and Industrial Pharmacy, 26(5), 523–529., [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Li, Y. Q., & Yang, Y. L. (1997). Clinical treatment by puerarin in patients with senile ischemic cerebrovascular disease. Zhongguo Yaoxue Zazhi, 32, 776–777., [CSA]
- Li, N., Lu, M., Chen, H., Meng, D. P., & Chen, Y. H. (2002). Pharmacokinetics of puerarin in patients with diabetic nephropathy. Chinese Journal of New Drugs and Clinical Remedies, 21, 51–53., [CSA]
- Liu, Q. G., Lu, Z. Y., & Wang, L. (2000). Restrictive effect of puerarin on myocardial infarct area in dogs and its possible mechanism. Journal of Tongji Medical University, 20(1), 43–45., [PUBMED], [INFOTRIEVE], [CSA]
- Porter, C. J. H., & Charman, W. N. (2001). In vitro assessment of oral lipid based formulations. Advanced Drug Delivery Reviews, 50, S127–S147., [PUBMED], [INFOTRIEVE], [CROSSREF]
- Pouton, C. W. (1997). Formulation of self-emulsifying drug delivery systems. Advanced Drug Delivery Reviews, 25, 47–58., [CSA], [CROSSREF]
- Shah, N. H., Carvajal, M. T., Patel, C. I., Infeld, M. H., & Malick, A. W. (1994). Self-emulsifying drug delivery systems (SEDDS) with polyglycolyzed glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. International Journal of Pharmaceutics, 106, 15–23., [CROSSREF]
- Swenson, E. S., & Curatolo, W. J. (1992). Means to enhance penetration. Advanced Drug Delivery Reviews, 8, 39–42., [CROSSREF]
- Zeng, G. Y., Zhang, L. Y., Zhou, Y. P., & Fan, L. L. (1979). Pharmacological studies on Radix puerariea. IV. Effects of puerariae flavones on plasma catecholamine levels in patients with hypertension and angina pectoris. Chung-hua I Hsueh Tsa Chih, 59, 479–482.